Related Experiment Video
Updated: Jul 16, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Peak flow variation in childhood asthma: a three-year analysis
J E Gern1, P A Eggleston, K C Schuberth
1Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD.
Insights
Peak expiratory flow (PEF) variation may not accurately reflect individual asthma control. However, mean diurnal variation (MDV) can be a useful indicator of asthma severity in group studies.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Respiratory Medicine
Background:
- Peak expiratory flow (PEF) variation is proposed as an indicator for asthma severity and bronchial hyperreactivity.
- Assessing PEF variation's utility in tightly controlled allergic asthma requires further investigation.
Purpose of the Study:
- To examine the relationship between PEF variation, methacholine reactivity, symptom scores, and medication needs in children with allergic asthma.
- To determine if PEF variation is a reliable indicator of asthma severity and bronchial hyperreactivity.
Main Methods:
- Studied 74 children with allergic asthma, measuring PEF variation (mean diurnal variation - MDV), methacholine reactivity, symptom scores, and medication requirements.
- Longitudinal analysis of 33 children over 36 months to track changes in MDV and other asthma variables.
Main Results:
- Statistically significant correlations were found between MDV and methacholine reactivity (r=0.43) and symptom scores (r=0.28).
- Visit-to-visit changes in MDV did not consistently reflect changes in other asthma metrics.
- Group MDV decreased over time, particularly in those with higher initial MDV, coinciding with reduced medication needs and methacholine reactivity.
Conclusions:
- Children with moderately severe, tightly controlled asthma may exhibit normal PEF variation.
- The correlation between PEF variation and asthma variables is too weak for individual patient treatment decisions.
- Mean diurnal variation (MDV) shows potential as a useful indicator of asthma severity in group research.
Abstract:
Measuring peak expiratory flow (PEF) variation has been suggested as a indicator of asthma disease severity and also of nonspecific bronchial hyperreactivity. To test these assumptions, we examined the relationships between PEF variation, methacholine reactivity, symptom scores, and medication requirements in 74 children with tightly controlled allergic asthma. The level of mean diurnal variation (MDV) for the group was 7.1%, which is generally regarded as normal. We found statistically significant correlations between MDV and both methacholine reactivity (r = 0.43, p = 0.0001) and symptom scores (r = 0.28, p = 0.016). These asthma variables were analyzed longitudinally in 33 children who were followed up at 6-month intervals for at least 36 months. Visit-to-visit changes in MDV were generally not reflective of changes in other variables. However, group levels of MDV gradually decreased over time, especially in children with initial MDV of more than 8%. This reduction in group MDV coincided with similar reductions in group medication requirements and methacholine reactivity. We conclude that children with moderately severe asthma that is tightly controlled may have normal levels of PEF variation. The correlation between PEF variation and other asthma variables is statistically significant but too weak to be useful in the treatment of individual patients. In contrast, measurement of MDV may be a useful indicator of disease severity in group studies of asthma.
Related Concept Videos
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Asthma-I: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma I: Introduction
Asthma III: Clinical Manifestations

